Invention Grant
- Patent Title: Anti-PD-1 antibodies, method for producing same and method for using same
-
Application No.: US16095800Application Date: 2017-07-04
-
Publication No.: US11136408B2Publication Date: 2021-10-05
- Inventor: Viktoriia Mikhailovna Ekimova , Dmitry Valeryevich Korzhavin , Yulia Sergeevna Chernykh , Timofey Aleksandrovich Nemankin , Valery Vladimirovich Solovyev , Anna Konstantinovna Vladimirova , Irina Andreevna Bulankina , Sergei Vasilyevich Diduk , Olga Vladimirovna Goncharova , Anna Vladimirovna Eroshova , Iakov Lurevich Ustiugov , Marina Vladimirovna Artiukhova , Andrei Borisovich Ulitin , Roman Alekseevich Ivanov , Dmitry Valentinovich Morozov
- Applicant: JOINT STOCK COMPANY “BIOCAD”
- Applicant Address: RU St.Petersburg
- Assignee: JOINT STOCK COMPANY “BIOCAD”
- Current Assignee: JOINT STOCK COMPANY “BIOCAD”
- Current Assignee Address: RU St.Petersburg
- Agency: Anglehart et al.
- Priority: RURU2016128487 20160713
- International Application: PCT/RU2017/050056 WO 20170704
- International Announcement: WO2018/013017 WO 20180118
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/28 ; C12N15/63 ; A61K39/395 ; A61P31/00 ; A61P35/00
Abstract:
The present invention relates to biotechnology and comprises isolated monoclonal antibodies, in particular human monoclonal antibodies, which specifically bind to PD-1 with high affinity. The antibodies according to the invention may be chimeric, humanized or human antibodies, or antigen-binding fragments thereof, and may be used as a medicinal agent in oncology and immuno-oncology, for treating diseases associated with various cell proliferation or development disorders. The invention also relates to methods for producing said antibodies and a method for treating human diseases using said antibodies.
Public/Granted literature
- US20190127478A1 ANTI-PD-1 ANTIBODIES, METHOD FOR PRODUCING SAME AND METHOD FOR USING SAME Public/Granted day:2019-05-02
Information query
